ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Can Autoimmune Conditions be Reversed? Researchers Make a Surprising Discovery

How One Tiny Molecule Turned into One Huge Health Breakthrough

Nutrients Boost Stem Cell Function

Humans have three times more brown body fat

B12 Proven Essential for Every Cell

Soy isoflavones may benefit breast cancer patients

How B Vitamins Improve Brain Health, Cognition, Psychiatric Problems and Mood Disorders

Dietary prebiotics improve sleep, buffer impacts of stress, says study

Ylang Ylang Oil Not Only Soothes Your Skin, but Your Mind as Well

Exercises to Help Prevent Urinary Incontinence

 
Print Page
Email Article

Two Alzheimer's Drugs Show Potential - U.S. Studies

  [ 282 votes ]   [ Discuss This Article ]
www.ProHealth.com • July 23, 2004


By Jon Hurdle

Two experimental Alzheimer's drugs have the potential to prevent or halt the progress of the brain-wasting disease, doctors said on Wednesday. Both focus on beta-amyloid, a protein that is suspected of causing Alzheimer's. It accumulates into the characteristic clogs called plaques that distinguish the brains of people who have died from Alzheimer's.

An estimated 4.5 million Americans have the disease, a number that is expected to grow to 16 million by 2050 as the baby boom generation ages. More than 15 million people globally have Alzheimer's.

In one study at Georgetown University Medical Center in Washington, 58 people with mild to moderate Alzheimer's disease (news - web sites) took a drug called Alzhemed or a placebo for three months, then for an additional 21 months. Alzhemed, made by Montreal, Canada-based Neurochem Inc., is a pill just beginning Phase III trials, the final stage before a company seeks approval from regulators for a new drug.

The study, reported at a meeting of Alzheimer's experts in Philadelphia, found a significant drop in the level of beta-amyloid among patients who took the drug and no change among those taking the placebo. The researchers also found Alzhemed in cerebral spinal fluid, which indicates it was finding its way to the brain where it is needed. The drug reduced the levels of beta-amyloid in the spinal fluid and was generally safe and well tolerated, the researchers found.

TRIAL SET TO EXPAND Among patients who began the trial with mild Alzheimer's, there was no further cognitive decline after 12 months of taking the drug, said Dr. Paul Aisen, who leads the study. There are now 26 patients who have taken the drug for 16 months, and 19 who have taken it for 20 months, Aisen told a news conference. He said the trial will now be expanded. "It will be a large, long trial that will provide a definitive answer on the efficacy of Alzhemed in inhibiting Alzheimer's," Aisen said.

In another study, Eli Lilly & Co. is trying to prevent beta-amyloid from forming in the first place. A trial of 37 healthy adults aged over 45 found blood levels of beta-amyloid were reduced after they took LY450139, an experimental drug designed to interfere with the formation enzymes called secretases, which generate beta-amyloid. The trial found reduced levels of beta-amyloid in the blood after the drug was administered. Higher doses produced a greater reduction. Although the drug was detected in cerebral spinal fluid, it did not reduce concentration of beta-amyloid in the fluid. Researchers need to know the most effective dose before starting a larger trial, said Dr. Eric Siemers of Eli Lilly.

Alzheimer's begins with mild memory loss but can quickly progress to destroy learning, memory and patients' ability to care for themselves. There is no cure and it is always fatal.

Source: Yahoo! news. (C) Reuters. All rights reserved.



Post a Comment

Featured Products From the ProHealth Store
Ultra EPA  - Fish Oil Ultra ATP+, Double Strength Vitamin D3 Extreme™

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products


Article Comments



Be the first to comment on this article!

Post a Comment


 
NAD+ Ignite with Niagen

Featured Products

Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength

Natural Remedies

Enhance Eyelashes Naturally Enhance Eyelashes Naturally
The Most Powerful Natural Antioxidant Discovered to Date - Hydroxytyrosol The Most Powerful Natural Antioxidant Discovered to Date - Hydroxytyrosol
The Remarkable Benefits of Reishi Medicinal Mushrooms The Remarkable Benefits of Reishi Medicinal Mushrooms
Quercetin: Natural Support for Allergy & Inflammation Relief and More Quercetin: Natural Support for Allergy & Inflammation Relief and More
The Crucial Role CoQ10 Plays in Fibromyalgia and ME/CFS The Crucial Role CoQ10 Plays in Fibromyalgia and ME/CFS

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map